LILRB2 Peptide - C-terminal region (AAP63917)

• Gene Aliases:

  CD85D, ILT4, LILRA6, LIR-2, LIR2, MIR-10, MIR10

• Gene ID:

  10288

• Accession Number:

  NP_005865

• Target:

  This is a synthetic peptide designed for use in combination with anti-LILRB2 Antibody (ARP63917_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

• Partner Proteins:

  FCGR1A, HLA-A, HLA-B, HLA-C, HLA-F, HLA-G, PTPN6, HLA-B, HLA-C, HLA-F, HLA-G, PTPN6

• Type:

  Blocking Peptide

• Applications:

  WB

• Assay Protocol:

  Reconstitution & Storage Instructions Western Blotting/Immunoblotting (WB/IB) Protocol Immunohistochemistry (IHC) Protocol Immunocytochemistry (ICC) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Blocking Peptide Competition Protocol (BPCP) Immunoprecipitation (IP) Protocol Antibody Array (AA) Protocol Reconstitution & Storage Instructions Reconstitution & Storage Instructions Western Blotting/Immunoblotting (WB/IB) Protocol Western Blotting/Immunoblotting (WB/IB) Protocol Immunohistochemistry (IHC) Protocol Immunohistochemistry (IHC) Protocol Immunocytochemistry (ICC) Protocol Immunocytochemistry (ICC) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Blocking Peptide Competition Protocol (BPCP) Blocking Peptide Competition Protocol (BPCP) Immunoprecipitation (IP) Protocol Immunoprecipitation (IP) Protocol Antibody Array (AA) Protocol Antibody Array (AA) Protocol

• Format:

  Lyophilized powder

• Reconstitution:

  Add 100ul of sterile PBS. Final peptide concentration is 1 mg/ml in PBS. For longer periods of storage, store at -20C. Avoid repeat freeze-thaw cycles.

• Molecular Weight:

  65kDa

• Protein Length:

  598

• Gene Name URL:

  LILRB2

• Nucleotide Accession Number:

  NM_005874